Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Downgrades MorphoSys to Equal-Weight

Morgan Stanley analyst James Quigley downgrades MorphoSys (NASDAQ:MOR) from Overweight to Equal-Weight.

byBenzinga Newsdesk

January 14, 2022

1 minute read

Morgan Stanley analyst James Quigley downgrades MorphoSys (NASDAQ:MOR) from Overweight to Equal-Weight.

Nvidia, GameStop, AMC — Stocks WallStreetBets Is Talking About Today

By Madhukumar Warrier

Today, 3:06 AM

SPDR S&P 500 ETF Trust (NYSE: SPY) continues to see the highest interest on Reddit’s r/WallStreetBets forum as of Monday night, followed by GameStop Corp. (NYSE: GME), Nvidia Corp. (NASDAQ:

AAPL

Cyanotech Q1 EPS $0.08 Up From $0.02 YoY, Sales $8.96M Up From $7.35M YoY

By Benzinga Newsdesk

Today, 3:06 AM

Cyanotech (NASDAQ:CYAN) reported quarterly earnings of $0.08 per share. This is a 300 percent increase over earnings of $0.02 per share from the same period last year. The company reported $8.96 million in sales this

CYAN

UBS Upgrades News to Buy

By Benzinga Newsdesk

Today, 3:06 AM

UBS analyst Tom Beadle upgrades News (NASDAQ:NWSA) from Neutral to Buy.

NWS

ADMA Biologics’ Aseptic Fill-Finish Machine Scores FDA Approval

By Vandana Singh

Today, 3:06 AM

The FDA has approved ADMA Biologics Inc’s (NASDAQ:ADMA) in-house aseptic fill-finish machine, the VanRx SA25. Related Content: ADMA Biologics Stock Gains On…

ADMA

Morgan Stanley Downgrades MorphoSys to Equal-Weight

Related Posts

Nvidia, GameStop, AMC — Stocks WallStreetBets Is Talking About Today

Cyanotech Q1 EPS $0.08 Up From $0.02 YoY, Sales $8.96M Up From $7.35M YoY

UBS Upgrades News to Buy

ADMA Biologics’ Aseptic Fill-Finish Machine Scores FDA Approval